We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 23.36%
This Fund
S&P 500
This Quarter Est. Return
+0.44%
1 Year Est. Return
+23.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33K
AUM Growth
-$107M
Cap. Flow
-$107M
Cap. Flow %
-322,946.95%
Top 10 Hldgs %
100%
Holding
2,163
New
1
Increased
–
Reduced
1
Closed
2,153

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$418K
2
GIS icon
General Mills
GIS
+$355K
3
WMT icon
Walmart Inc
WMT
+$303K
4
K
Kellanova
K
+$292K
5
PEP icon
PepsiCo
PEP
+$277K

Sector Composition

Rank Sector Weight
1 Healthcare 9.09%
2 Consumer Discretionary 0%
3 Consumer Staples 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHP icon
176
BHP
BHP
$213B
– –
-4,803
Closed -$153K
BIO icon
177
Bio-Rad Laboratories Class A
BIO
$8.42B
– –
-200
Closed -$45K
BIP icon
178
Brookfield Infrastructure Partners
BIP
$18.8B
– –
-420
Closed -$10K
BNY
179
Bank of New York Mellon
BNY
$108B
– –
-1,000
Closed -$51K
BKD icon
180
Brookdale Senior Living
BKD
$3.62B
– –
-574
Closed -$8K
BKH icon
181
Black Hills Corp
BKH
$5.73B
– –
-400
Closed -$27K
BKU icon
182
Bankunited
BKU
$3.38B
– –
-666
Closed -$22K
BLBD icon
183
Blue Bird Corp
BLBD
$2.41B
– –
-701
Closed -$12K
BLD
184
DELISTED
TopBuild
BLD
– –
-1,178
Closed -$63K
BLK icon
185
Blackrock
BLK
$164B
– –
-200
Closed -$84K
BLKB icon
186
Blackbaud
BLKB
$1.5B
– –
-426
Closed -$37K
BLMN icon
187
Bloomin' Brands
BLMN
$680M
– –
-2,229
Closed -$47K
BLX icon
188
Bladex Inc
BLX
$2.24B
– –
-835
Closed -$23K
BMI icon
189
Badger Meter
BMI
$3.66B
– –
-1,761
Closed -$70K
BMRN icon
190
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-400
Closed -$36K
BN icon
191
Brookfield
BN
$102B
– –
-813
Closed -$11K
BMY icon
192
Bristol-Myers Squibb
BMY
$127B
– –
-2,200
Closed -$123K
BNED icon
193
Barnes & Noble Education
BNED
$412M
– –
-14
Closed -$15K
BNTC icon
194
Benitec Biopharma
BNTC
$394M
– –
-28
Closed -$13K
BOKF icon
195
BOK Financial
BOKF
$8.64B
– –
-400
Closed -$34K
BOX icon
196
Box
BOX
$4.02B
– –
-451
Closed -$8K
BP icon
197
BP
BP
$113B
– –
-1,579
Closed -$49K
BPOP icon
198
Popular Inc
BPOP
$11B
– –
-2,021
Closed -$84K
BPT
199
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
– –
-2,670
Closed -$58K
BR icon
200
Broadridge
BR
$17.2B
– –
-1,423
Closed -$108K
6 7
8
9 10

Similar funds

CRAM
Claren Road Asset Management New York $891K AUM
ABFS
Appropriate Balance Financial Services Bellevue, Washington $2.01M AUM 19.83% 1-Year Est. Return
VHS
Vitol Holding (Switzerland) Geneva, Switzerland $4.12M AUM
ACM
Addison Clark Management Stamford, Connecticut $5M AUM 6.65% 1-Year Est. Return
SIM
Summitview Investment Management Grand Cayman, Cayman Islands $6.18M AUM
MC
Mitra Capital Boston, Massachusetts $10.2M AUM 51.14% 1-Year Est. Return
TU
Teilinger USA Houston, Texas $12.7M AUM
ASB
Amundi Smith Breeden Durham, North Carolina $18.8M AUM

Acrospire Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Acrospire Investment Management held 2,163 positions worth $33K, down 100% from $107M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Acrospire Investment Management withdrew a net $107M in Q3 2017, closing 2,153 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $418K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Acrospire Investment Management's biggest Q3 2017 reduction was Patheon N.V., cutting an estimated $3.49K.
  • Acrospire Investment Management fully exited Procter & Gamble in Q3 2017, selling an estimated $418K.
  • Acrospire Investment Management's ten largest holdings make up 100% of its $33K portfolio in Q3 2017.
  • Acrospire Investment Management opened 1 new position and closed 2,153 in Q3 2017.
  • Acrospire Investment Management's portfolio value fell 100% quarter-over-quarter to $33K.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.